NEW YORK (GenomeWeb) – Premaitha Health and Coastal Genomics have signed an agreement to develop technologies for clinical DNA sequencing tests, Premaitha said today.

Under the agreement, Coastal Genomics, based in Vancouver, and Premaitha, located in Manchester, UK, plan to develop technologies "to enhance aspects of Premaitha Health's in vitro diagnostic product portfolio" for reproductive health and other applications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

Jan
31
Sponsored by
Roche

This webinar highlights the use of single-cell genomics to identify distinct cell types and states associated with enhanced immunity.